Retinopathy of Prematurity Clinical Trials

Find Retinopathy of Prematurity Clinical Trials Near You

The Correlation Between Packed Red Blood Cell Transfusion and Early and Late Complications of Prematurity

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

The aim of this clinical trial is to learn if there is a correlation between the erythrocyte transfusion in the early neonatal period in premature infants and early and late complications of prematurity. The main questions it aims to answer are: * Do premature infants who receive blood transfusions within their first month of life have a higher risk of early prematurity complications, such as retinopathy of prematurity, necrotising enterocolitis, bronchopulmonary dysplasia, and intraventricular haemorrhage? * Do premature infants who receive blood transfusions during their first month of life have worse neurological and neurodevelopmental outcomes than those who do not? The first part of the study is retrospective, using data collected from participants' histories. The second part is prospective, evaluating neurological and neurodevelopmental outcomes at the age of six years.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 6
Maximum Age: 7
Healthy Volunteers: f
View:

• all children born as premature infants \<32. weeks of gestation in Clinical Hospital Centre Rijeka from June 2018. to December 2021. (and who will be on September 2025. six years old)

• signed informed consent

Locations
Other Locations
Croatia
Clinical Hospital Centre Rijeka, Department of Paediatrics
RECRUITING
Rijeka
Contact Information
Primary
Kristina Lah Tomulić
kristina.lah.tomulic@medri.uniri.hr
+385992015885
Backup
senada šerifi
senada.serifi@medri.uniri.hr
Time Frame
Start Date: 2025-09-01
Estimated Completion Date: 2029-03-01
Participants
Target number of participants: 128
Treatments
Assesment of the neurological and neurodevelopmental outcome at the age of six
All premature infants (less than 32 weeks of gestation) will be neurologically assessed at the age of six. Also, their neurodevelopmental outcome will be assessed at the age of six using the Wechsler Intelligence Test.
Sponsors
Leads: Clinical Hospital Center Rijeka

This content was sourced from clinicaltrials.gov